The Molecular Biology Society of Japan

The 45th Annual Meeting of the Molecular Biology Society of Japan

The 45th Annual Meeting of the Molecular Biology Society of Japan

Nov 30, 2022 - Dec 2, 2022
Makuhari Messe, Chiba

[3P-656] Benefits of combined treatment of HDAC inhibitor and TOPO isomerase inhibitor on synovial sarcoma cells

○Satoru Sasagawa1, Toru Wakamatsu2, Jun Kumai3, Yoshihiro Yui3 (1.Mol. Biol. Lab., Res. Inst., Nozaki Tokushukai HP, 2.Dept. Musculoskeletal Oncol., Osaka Int. Cancer Ctr., 3.Sarcoma treat. Lab., Res. Inst., Nozaki Tokushukai HP)

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password